Leveraging the molecular insights and therapeutic potential of diet-derived-flavonoids against pancreatic ductal adenocarcinoma
Introduction Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies of the gastrointestinal tract, characterized by its subtle onset, aggressive progression, and poor prognosis. Due to intrinsic resistance to drugs and high relapse rates after conventional therapies, the need to investigate...